Cannabis cos, ETFs fall on news FDA weighing regulating CBD in food, supplements

Organigram Global

27/12/2022 18:23

** U.S.-listed shares of cannabis companies and ETFs fall
after report that FDA weighing recommendations on regulation of
CBD in food and supplements
    ** FDA wants to know if CBD can be safely eaten every day
for a long period or during pregnancy amid concerns about future
fertility, Patrick Cournoyer, who heads FDA office that is
developing agency's cannabis strategy, told WSJ
    ** Cannabidiol, or CBD, is non-psychoactive compound found
in cannabis
    ** Shares of cannabis companies Tilray Brands  TLRY.O ,
Aurora Cannabis  ACB.O , Canopy Growth Corp  CGC.O  and
OrganiGram  OGI.O  fall between 2.7% and 7.7%
    ** Cannabis ETFs ETFMG US Alternative Harvest  MJUS.P ,
ETFMG Alternative Harvest  MJ.P  and AdvisorShares Pure US
Cannabis  MSOS.P  fall between 2.6% and 4.9%
 (Reporting by Arshreet Singh in Bengaluru)
 ((Arshreet.Singh@thomsonreuters.com))